Published in AIDS Res Hum Retroviruses on November 01, 2007
Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS (2011) 6.26
Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol (2010) 1.28
Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. J Immunol Methods (2014) 0.97
Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance. J Clin Microbiol (2010) 0.88
Use of quantitative HIV RNA detection for early diagnosis of HIV infection in infants and acute HIV infections in Alberta, Canada. J Clin Microbiol (2011) 0.84
Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil. Virol J (2012) 0.82
Comparison on virulence and immunogenicity of two recombinant vaccinia vaccines, Tian Tan and Guang9 strains, expressing the HIV-1 envelope gene. PLoS One (2012) 0.76
An avoidable transmission of HIV from mother to child. CMAJ (2010) 0.76
Evaluation of Hologic Aptima HIV-1 Quant Dx Assay on the Panther System on HIV Subtypes. J Clin Microbiol (2016) 0.75
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest (2003) 2.21
Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol (2010) 1.28
The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population. Health Policy (2008) 1.09
Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis (2012) 1.08
Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol (2004) 0.98
Protein bead array for the detection of HIV-1 antibodies from fresh plasma and dried-blood-spot specimens. Clin Chem (2004) 0.88
Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS. AIDS Res Hum Retroviruses (2005) 0.85
Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo. Curr HIV Res (2008) 0.83
Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort. AIDS Res Hum Retroviruses (2005) 0.83
Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort. Retrovirology (2005) 0.83
Increasing HIV subtype diversity in Canadian-born patients living in Southern Alberta, Canada. J Acquir Immune Defic Syndr (2011) 0.83
The cost of antiretroviral drug resistance in HIV-positive patients. Antivir Ther (2013) 0.81
A combined HIV-1 protein bead array for serology assay and T-cell subset immunophenotyping with a hybrid flow cytometer: a step in the direction of a comprehensive multitasking instrument platform for infectious disease diagnosis and monitoring. Cytometry B Clin Cytom (2006) 0.76
Limitations of opt-out HIV screening and mother-child HIV transmission. Am J Public Health (2010) 0.76
The changing demographics of women living with HIV/AIDS in southern Alberta from 1982 to 2006. Can J Infect Dis Med Microbiol (2012) 0.75
Identification of mutations in proviral long terminal repeats of HIV type 1-infected subjects naive to drug therapy. AIDS Res Hum Retroviruses (2004) 0.75
Z-FA-FMK as a novel potent inhibitor of reovirus pathogenesis and oncolysis in vivo. Antivir Ther (2010) 0.75